title: Toward dissecting the etiology of schizophrenia: HDAC1 and DAXX regulate GAD67 expression in an in vitro hippocampal GABA neuron model.
abstract: Schizophrenia (SZ) is associated with GABA neuron dysfunction in the hippocampus, particularly the stratum oriens of sector CA3/2. A gene expression profile analysis of human postmortem hippocampal tissue followed by a network association analysis had shown a number of genes differentially regulated in SZ, including the epigenetic factors HDAC1 and DAXX. To characterize the contribution of these factors to the developmental perturbation hypothesized to underlie SZ, lentiviral vectors carrying short hairpin RNA interference (shRNAi) for HDAC1 and DAXX were used. In the hippocampal GABA neuron culture model, HiB5, transduction with HDAC1 shRNAi showed a 40% inhibition of HDAC1 mRNA and a 60% inhibition of HDAC1 protein. GAD67, a enzyme associated with GABA synthesis, was increased twofold (mRNA); the protein showed a 35% increase. The expression of DAXX, a co-repressor of HDAC1, was not influenced by HDAC1 inhibition. Transduction of HiB5 cells with DAXX shRNAi resulted in a 30% inhibition of DAXX mRNA that translated into a 90% inhibition of DAXX protein. GAD1 mRNA was upregulated fourfold, while its protein increased by ~30%. HDAC1 expression was not altered by inhibition of DAXX. However, a physical interaction between HDAC1 and DAXX was demonstrated by co-immunoprecipitation. Inhibition of HDAC1 or DAXX increased expression of egr-1, transcription factor that had previously been shown to regulate the GAD67 promoter. Our in vitro results point to a key role of both HDAC1 and DAXX in the regulation of GAD67 in GABAergic HiB5 cells, strongly suggesting that these epigenetic/transcription factors contribute to mechanisms underlying GABA cell dysfunction in SZ.
authors.affiliation: Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.|Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Subburaju
authors.affiliation: Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Coleman
authors.affiliation: Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.|Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
authors.forename: W B
authors.initials: WB
authors.lastname: Ruzicka
authors.affiliation: Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.|Department of Psychiatry, Harvard Medical School, Boston, MA, USA.|Program in Neuroscience, Harvard Medical School, Boston, MA, USA.
authors.forename: F M
authors.initials: FM
authors.lastname: Benes
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D056970:Co-Repressor Proteins; D059330:GABAergic Neurons / Q000378:metabolism*; D015870:Gene Expression / Q000235:genetics; D005968:Glutamate Decarboxylase / Q000235:genetics* / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism*; D056284:Histone Deacetylase 1 / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D018832:Molecular Chaperones; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D012559:Schizophrenia / Q000235:genetics* / Q000378:metabolism
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D056970:Co-Repressor Proteins; C106985:DAXX protein, human; D018832:Molecular Chaperones; D009687:Nuclear Proteins; C110550:HDAC1 protein, human; D056284:Histone Deacetylase 1; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20935-40
references.pmid: 19104056
references.citation: Ciba Found Symp. 1991;156:155-63; discussion 163-70
references.pmid: 1855409
references.citation: JAMA Psychiatry. 2015 Jun;72(6):541-51
references.pmid: 25738424
references.citation: Synapse. 1998 Aug;29(4):323-32
references.pmid: 9661250
references.citation: Nat Genet. 2000 Jan;24(1):88-91
references.pmid: 10615135
references.citation: Mol Cell Biol. 2000 Mar;20(5):1784-96
references.pmid: 10669754
references.citation: Mol Pharmacol. 2009 Feb;75(2):342-54
references.pmid: 19029285
references.citation: Schizophr Bull. 1992;18(2):319-32
references.pmid: 1377834
references.citation: EMBO J. 2013 Dec 11;32(24):3176-91
references.pmid: 24240174
references.citation: Nat Rev Cancer. 2006 Jan;6(1):38-51
references.pmid: 16397526
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11731-6
references.pmid: 19564623
references.citation: Science. 1996 Nov 1;274(5288):740-3
references.pmid: 8966556
references.citation: Appl Microbiol Biotechnol. 2007 Jun;75(3):487-97
references.pmid: 17377789
references.citation: Arch Gen Psychiatry. 1995 Apr;52(4):258-66
references.pmid: 7702443
references.citation: Schizophr Res. 2004 Dec 1;71(2-3):405-16
references.pmid: 15474912
references.citation: Trends Biochem Sci. 2006 Feb;31(2):89-97
references.pmid: 16403636
references.citation: Gene. 2014 May 25;542(1):77-82
references.pmid: 24630965
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9
references.pmid: 17553960
references.citation: Psychiatr Q. 2006 Spring;77(1):81-95
references.pmid: 16397757
references.citation: J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30
references.pmid: 12140263
references.citation: J Cell Sci. 2012 Jun 1;125(Pt 11):2732-9
references.pmid: 22393235
references.citation: Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
references.pmid: 11074872
references.citation: PLoS One. 2007 Aug 29;2(8):e809
references.pmid: 17726539
references.citation: PLoS One. 2012;7(3):e33352
references.pmid: 22457755
references.citation: Nature. 2010 Nov 11;468(7321):187-93
references.pmid: 21068826
references.citation: Am J Psychiatry. 2008 Mar;165(3):312
references.pmid: 18316429
references.citation: Cell. 2007 Feb 23;128(4):693-705
references.pmid: 17320507
references.citation: J Clin Invest. 2005 Jun;115(6):1440-8
references.pmid: 15931379
references.citation: Nat Rev Neurosci. 2010 Feb;11(2):100-13
references.pmid: 20087360
references.citation: Biol Psychiatry. 2011 Jan 15;69(2):102-3
references.pmid: 21183008
references.citation: Dev Biol. 1994 Sep;165(1):243-56
references.pmid: 8088442
references.citation: Appl Biochem Biotechnol. 2013 Jan;169(2):688-94
references.pmid: 23271624
references.citation: Mol Psychiatry. 2007 Apr;12(4):385-97
references.pmid: 17264840
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):239-57
references.pmid: 19727065
references.citation: Neuropharmacology. 2011 Jun;60(7-8):1007-16
references.pmid: 21074545
references.citation: Crit Rev Neurobiol. 2003;15(2):121-42
references.pmid: 14977367
references.citation: Arch Gen Psychiatry. 2012 Jun;69(6):550-61
references.pmid: 22309971
references.citation: J Neurosci. 2009 Jun 24;29(25):8288-97
references.pmid: 19553468
references.citation: DNA Seq. 2001;11(6):485-99
references.pmid: 11696975
references.citation: Neurobiol Dis. 2012 May;46(2):255-62
references.pmid: 22182689
references.citation: Nature. 2008 Oct 16;455(7215):919-23
references.pmid: 18923514
references.citation: J Biol Chem. 2008 Sep 5;283(36):24789-800
references.pmid: 18606818
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):348-53
references.pmid: 14684836
references.citation: J Neurosci. 2007 Oct 17;27(42):11254-62
references.pmid: 17942719
references.citation: Cell. 1991 Aug 23;66(4):713-29
references.pmid: 1878969
references.citation: Cell. 2007 Feb 23;128(4):707-19
references.pmid: 17320508
references.citation: Eur J Neurosci. 1996 Aug;8(8):1707-17
references.pmid: 8921261
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):16973-8
references.pmid: 16287980
references.citation: J Exp Med. 2000 Feb 21;191(4):631-40
references.pmid: 10684855
references.citation: J Neurosci. 2010 Sep 29;30(39):13130-7
references.pmid: 20881131